January 4, 2018 / 12:29 PM / in 19 days

BRIEF-Psivida Granted Waiver By The FDA For New Drug Application Filing Fee

Jan 4 (Reuters) - Psivida Corp:

* PSIVIDA GRANTED WAIVER BY THE FDA FOR NEW DRUG APPLICATION FILING FEE

* PSIVIDA CORP - ON TRACK TO FILE DURASERT NDA IN EARLY JANUARY

* PSIVIDA - FDA GRANTED BUSINESS WAIVER OF PDUFA FEE OF ABOUT $2.4 MILLION FOR NDA FOR CO‘S DURASERT 3 YEAR MICROINSERT FOR POSTERIOR SEGMENT UVEITIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below